Effect of an Intervention Program of Adapted Physical Activity Combined With Compensatory Nutrition in Patients With Constitutional Thinness (ANIMATION)

Constitutional Thinness (CT) is a form of stable thinness without malnutrition but with resistance to weight gain, affecting approximately 1% of the general population. The clinical consequences are numerous and the pathophysiology remains poorly understood.

Currently, conventional management involves a high-calorie and frequent diet, combined with the avoidance of endurance physical activity, although there is no significant evidence of its effectiveness.

Our hypothesis is that an adapted physical activity program (APA) combined with compensatory nutrition (CN) could help these patients gain lean mass (muscle mass).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • France
      • Saint-Etienne, France, France, 42055
        • Recruiting
        • CHU de Saint-Etienne
        • Sub-Investigator:
          • Léonard FEASSON, PhD
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Bogdan GALUSCA, PhD
        • Sub-Investigator:
          • David HUPIN, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Gender: Female
  • BMI: ≤ 18.5 kg/m²
  • Weight Stability: Stable weight for at least 3 months
  • Age: 18 to 50 years old at the inclusion visit
  • Diagnosed with Constitutional thinness

Exclusion Criteria:

  • Pregnancy, Parturition, or Lactation
  • Legal Restrictions: Individuals deprived of liberty, involuntarily hospitalized, or hospitalized for reasons other than research purposes, adults under legal protection (guardianship or curatorship) or unable to provide consent
  • Eating Disorders: Individuals with eating disorders (DSM IV and 5 criteria)
  • Excessive Alcohol Consumption: Consumption exceeding the equivalent of 10 glasses of wine per week
  • Severe Progressive Conditions: Progressive severe conditions (e.g., diabetes)
  • Intense Physical Activity: Individuals engaging in intense physical activity (> 3 sessions per week)
  • Heavy Smoking: Significant smoking (>10 cigarettes per day)
  • Psychiatric Conditions: Presence of depressive or psychiatric conditions requiring antidepressant or psychotropic treatment
  • Medical or Surgical History: Medical or surgical history deemed incompatible with the study by the investigator
  • MRI Contraindication: Individuals with contraindications to MRI will not undergo spectro-MRI analyses

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: APA + NC
The APA intervention will consist of a 2-week running-in period, followed by a period of adapted physical activity (APA) for 8 weeks.
The Compensatory Nutrition (NC) intervention will consist of a 2-week running-in period, followed by a period of compensated nutrition (NC) for 8 weeks.
No Intervention: Control
  • 2-week run-in period
  • Followed by an 8-week period of conventional management without APA and without NC

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lean body mass
Time Frame: From day 1 to week 8
Lean body mass gain (kg) measured by bioimpedance
From day 1 to week 8

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BMI
Time Frame: From day 1 to week 8
Body masse index : ratio between weight and height
From day 1 to week 8
Energy balance
Time Frame: From day 1 to week 8

Ratio between calorie intake and calorie expenditure

Caloric intake measured by dietary records over 2 weeks (calorie); Calorie expenditure: Resting metabolism measured by indirect calorimetry (kcal/24h); + Postprandial thermogenesis measured by indirect calorimetry (kcal/24h);; + Physical activity energy expenditure measured by connected watch (kcal/24h);

From day 1 to week 8
Physical exercise capacity
Time Frame: From day 1 to week 8
Changes in VO2max
From day 1 to week 8
Quality of life SF-12 questionnaire
Time Frame: From day 1 to week 8
SF-12 questionnaire; Self-measurement questionnaire SF-12 (Short Form Health Survey 12); comprising 12 questions assessing 8 dimensions, namely physical functioning, role limitation due to physical problems, role limitation resulting from emotional problems, vitality (energy/fatigue), emotional well-being, social functioning, bodily pain, and perception of general and mental health; each dimension is represented by a score ranging from 0 to 100, with a low score signifying poor health perception in the dimension considered, and a high score signifying the opposite);
From day 1 to week 8

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 7, 2025

Primary Completion (Estimated)

March 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

February 4, 2025

First Submitted That Met QC Criteria

March 18, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Estimated)

October 7, 2025

Last Update Submitted That Met QC Criteria

October 2, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 24CH263
  • ANSM (Other Identifier: 2025-A01697-42)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Constitutional Thinness

Clinical Trials on Adapted Physical Activity (APA)

Subscribe